Federal Trade Commission Extends Public Comment Period for Request for Information on Impact of Pharmacy Benefit Managers (PBMs)

Excerpt:  “The Federal Trade Commission is extending the public comment period, until May 25, 2022, on a request for information that covers a wide range of issues in the PBM market – including contract terms, rebates, fees, pricing policies, steering methods, conflicts of interest, and consolidation. The agency seeks information on these practices and their impact on patients, physicians, employers, independent and chain pharmacies, and other businesses across the distribution system.”